DuoCort Pharma Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $32.8M

DuoCort Pharma General Information

Description

Provider of drug development services focused on improving glucocorticoid therapy. The company has developed Plenadren, a glucocorticoid replacement therapy for patients with adrenal insufficiency, which is a rare disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Kullagatan 8
  • 252 20 Helsingborg
  • Sweden
+46 042-12
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • Kullagatan 8
  • 252 20 Helsingborg
  • Sweden
+46 042-12

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DuoCort Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 27-Oct-2011 $32.8M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view DuoCort Pharma’s complete valuation and funding history, request access »

DuoCort Pharma Patents

DuoCort Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2013526552-A Dosage and novel administration methods for glucocorticoid-based compositions Inactive 20-May-2010
CA-2799820-A1 Posology and administration of glucocorticoid based compositions Inactive 20-May-2010
AU-2011254959-A1 Posology and administration of glucocorticoid based compositions Inactive 20-May-2010
US-20130209565-A1 Posology and administration of glucocorticoid based compositions Inactive 20-May-2010
AU-2015200457-A1 Improved glucocorticoid therapy Inactive 07-Apr-2009
To view DuoCort Pharma’s complete patent history, request access »

DuoCort Pharma Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aqilion Corporation Minority
To view DuoCort Pharma’s complete investors history, request access »

DuoCort Pharma FAQs

  • When was DuoCort Pharma founded?

    DuoCort Pharma was founded in 2004.

  • Where is DuoCort Pharma headquartered?

    DuoCort Pharma is headquartered in Helsingborg, Sweden.

  • What industry is DuoCort Pharma in?

    DuoCort Pharma’s primary industry is Biotechnology.

  • Is DuoCort Pharma a private or public company?

    DuoCort Pharma is a Private company.

  • What is the current valuation of DuoCort Pharma?

    The current valuation of DuoCort Pharma is .

  • What is DuoCort Pharma’s current revenue?

    The current revenue for DuoCort Pharma is .

  • Who are DuoCort Pharma’s investors?

    Aqilion has invested in DuoCort Pharma.

  • When was DuoCort Pharma acquired?

    DuoCort Pharma was acquired on 27-Oct-2011.

  • Who acquired DuoCort Pharma?

    DuoCort Pharma was acquired by ViroPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »